Literature DB >> 28555383

New fronts emerge in the influenza cytokine storm.

Xi-Zhi J Guo1,2, Paul G Thomas3,4.   

Abstract

Influenza virus is a significant pathogen in humans and animals with the ability to cause extensive morbidity and mortality. Exuberant immune responses induced following infection have been described as a "cytokine storm," associated with excessive levels of proinflammatory cytokines and widespread tissue damage. Recent studies have painted a more complex picture of cytokine networks and their contributions to clinical outcomes. While many cytokines clearly inflict immunopathology, others have non-pathological delimited roles in sending alarm signals, facilitating viral clearance, and promoting tissue repair, such as the IL-33-amphiregulin axis, which plays a key role in resolving some types of lung damage. Recent literature suggests that type 2 cytokines, traditionally thought of as not involved in anti-influenza immunity, may play an important regulatory role. Here, we discuss the diverse roles played by cytokines after influenza infection and highlight new, serene features of the cytokine storm, while highlighting the specific functions of relevant cytokines that perform unique immune functions and may have applications for influenza therapy.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28555383      PMCID: PMC5580809          DOI: 10.1007/s00281-017-0636-y

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  113 in total

Review 1.  Regulation of type I interferon responses.

Authors:  Lionel B Ivashkiv; Laura T Donlin
Journal:  Nat Rev Immunol       Date:  2014-01       Impact factor: 53.106

Review 2.  Innate immune responses to influenza A H5N1: friend or foe?

Authors:  Joseph Sriyal Malik Peiris; Chung Yan Cheung; Connie Yin Hung Leung; John Malcolm Nicholls
Journal:  Trends Immunol       Date:  2009-10-26       Impact factor: 16.687

3.  Interleukin-6 limits influenza-induced inflammation and protects against fatal lung pathology.

Authors:  Sarah N Lauder; Emma Jones; Kathryn Smart; Anja Bloom; Anwen S Williams; James P Hindley; Beatrice Ondondo; Philip R Taylor; Mathew Clement; Ceri Fielding; Andrew J Godkin; Simon A Jones; Awen M Gallimore
Journal:  Eur J Immunol       Date:  2013-08-12       Impact factor: 5.532

4.  Clinical aspects and cytokine response in severe H1N1 influenza A virus infection.

Authors:  Natalia Hagau; Adriana Slavcovici; Daniel N Gonganau; Simona Oltean; Dan S Dirzu; Erika S Brezoszki; Mihaela Maxim; Constantin Ciuce; Monica Mlesnite; Rodica L Gavrus; Carmen Laslo; Radu Hagau; Magda Petrescu; Daniela M Studnicska
Journal:  Crit Care       Date:  2010-11-09       Impact factor: 9.097

5.  Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasmacytoid dendritic cells.

Authors:  Corine H GeurtsvanKessel; Monique A M Willart; Leonie S van Rijt; Femke Muskens; Mirjam Kool; Chantal Baas; Kris Thielemans; Clare Bennett; Björn E Clausen; Henk C Hoogsteden; Albert D M E Osterhaus; Guus F Rimmelzwaan; Bart N Lambrecht
Journal:  J Exp Med       Date:  2008-07-07       Impact factor: 14.307

Review 6.  Balancing Immune Protection and Immune Pathology by CD8(+) T-Cell Responses to Influenza Infection.

Authors:  Susu Duan; Paul G Thomas
Journal:  Front Immunol       Date:  2016-02-05       Impact factor: 7.561

7.  Inflammasome recognition of influenza virus is essential for adaptive immune responses.

Authors:  Takeshi Ichinohe; Heung Kyu Lee; Yasunori Ogura; Richard Flavell; Akiko Iwasaki
Journal:  J Exp Med       Date:  2009-01-12       Impact factor: 14.307

8.  Response to influenza infection in mice with a targeted disruption in the interferon gamma gene.

Authors:  M B Graham; D K Dalton; D Giltinan; V L Braciale; T A Stewart; T J Braciale
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

9.  Type 2 innate lymphoid cells control eosinophil homeostasis.

Authors:  Jesse C Nussbaum; Steven J Van Dyken; Jakob von Moltke; Laurence E Cheng; Alexander Mohapatra; Ari B Molofsky; Emily E Thornton; Matthew F Krummel; Ajay Chawla; Hong-Erh Liang; Richard M Locksley
Journal:  Nature       Date:  2013-09-15       Impact factor: 49.962

10.  Reassessing the role of the NLRP3 inflammasome during pathogenic influenza A virus infection via temporal inhibition.

Authors:  Michelle D Tate; James D H Ong; Jennifer K Dowling; Julie L McAuley; Avril B Robertson; Eicke Latz; Grant R Drummond; Matthew A Cooper; Paul J Hertzog; Ashley Mansell
Journal:  Sci Rep       Date:  2016-06-10       Impact factor: 4.379

View more
  100 in total

1.  Critical Adverse Impact of IL-6 in Acute Pneumovirus Infection.

Authors:  Caroline M Percopo; Michelle Ma; Todd A Brenner; Julia O Krumholz; Timothy J Break; Karen Laky; Helene F Rosenberg
Journal:  J Immunol       Date:  2018-12-21       Impact factor: 5.422

2.  IL-36γ Protects against Severe Influenza Infection by Promoting Lung Alveolar Macrophage Survival and Limiting Viral Replication.

Authors:  Alexander N Wein; Paul R Dunbar; Sean R McMaster; Zheng-Rong Tiger Li; Timothy L Denning; Jacob E Kohlmeier
Journal:  J Immunol       Date:  2018-05-30       Impact factor: 5.422

3.  Increased TSLP, IL-33, IL-25, IL-19, IL 21 and amphiregulin (AREG) levels in chronic rhinosinusitis with nasal polyp.

Authors:  Murat Dogan; Mustafa Sahin; Cigdem Yenisey
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-03-19       Impact factor: 2.503

Review 4.  Role of inflammatory markers in corona virus disease (COVID-19) patients: A review.

Authors:  Jyoti Upadhyay; Nidhi Tiwari; Mohd N Ansari
Journal:  Exp Biol Med (Maywood)       Date:  2020-07-07

5.  Pathogenesis of Influenza A(H7N9) Virus in Aged Nonhuman Primates.

Authors:  Satoshi Fukuyama; Kiyoko Iwatsuki-Horimoto; Maki Kiso; Noriko Nakajima; Robert W Gregg; Hiroaki Katsura; Yuriko Tomita; Tadashi Maemura; Tiago Jose da Silva Lopes; Tokiko Watanabe; Jason E Shoemaker; Hideki Hasegawa; Seiya Yamayoshi; Yoshihiro Kawaoka
Journal:  J Infect Dis       Date:  2020-09-01       Impact factor: 5.226

6.  Lung γδ T Cells Mediate Protective Responses during Neonatal Influenza Infection that Are Associated with Type 2 Immunity.

Authors:  Xi-Zhi J Guo; Pradyot Dash; Jeremy Chase Crawford; E Kaitlynn Allen; Anthony E Zamora; David F Boyd; Susu Duan; Resha Bajracharya; Walid A Awad; Nopporn Apiwattanakul; Peter Vogel; Thirumala-Devi Kanneganti; Paul G Thomas
Journal:  Immunity       Date:  2018-08-28       Impact factor: 31.745

7.  Long Noncoding RNA Lnc-MxA Inhibits Beta Interferon Transcription by Forming RNA-DNA Triplexes at Its Promoter.

Authors:  Xinda Li; Guijie Guo; Min Lu; Wenjia Chai; Yucen Li; Xiaomei Tong; Jing Li; Xiaojuan Jia; Wenjun Liu; Dandan Qi; Xin Ye
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

8.  Testosterone treatment of aged male mice improves some but not all aspects of age-associated increases in influenza severity.

Authors:  Landon G Vom Steeg; Sarah E Attreed; Barry Zirkin; Sabra L Klein
Journal:  Cell Immunol       Date:  2019-09-14       Impact factor: 4.868

9.  Alternaria alternata challenge at the nasal mucosa results in eosinophilic inflammation and increased susceptibility to influenza virus infection.

Authors:  M Ma; J L Redes; C M Percopo; K M Druey; H F Rosenberg
Journal:  Clin Exp Allergy       Date:  2018-04-15       Impact factor: 5.018

Review 10.  Adipocyte inflammation and pathogenesis of viral pneumonias: an overlooked contribution.

Authors:  Pablo C Alarcon; Michelle S M A Damen; Rajat Madan; George S Deepe; Paul Spearman; Sing Sing Way; Senad Divanovic
Journal:  Mucosal Immunol       Date:  2021-05-06       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.